Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by jfm1330on Jan 24, 2022 12:14pm
205 Views
Post# 34353289

RE:RE:RE:The No News Surprise

RE:RE:RE:The No News Surprise
This board is crazy as it was during the long wait for Trogarzo's approval and we see now the same kind of complaints. Remember during the Trogazo's BLA review a delay was announced. It went crazy here with all kind of negative scenarios to explain it. In the end, everything was fine, the drug got approved, the SP rose above 14$ and almost nobody took advantage of it. 14$ was only the first step, it was supposed to go much higher. This board went from too negative, to unrealisticly positive. This missed opportunity to make a lot of money is the real reason for the general frustration here, not the last financing which was a necessry move.
 
This time the really important thing is the result of the phase Ia. We need a clear proof of concept, or at least a strong indication that the concept works. After that it will be phase Ib and that will be the new very important thing and the new waiting period. Imagine where the company would be if Tanguay did not give the green light to the acquisition of Katana. At the time it was seen as a minor gamble by almost everybody here. I saw it as a good unexpensive educated guess, a good strategic move. But, hey, Tanguay was seen by many as an incompetent fool. Now it's the turn of Levesque. Heroes have a short shelf life around here...
 


ANALIAS00 wrote: It is not the first time they are doing this (removing the presentation for a long period). So to me it is just a bad habit and they just believe this is not important to them. But to me it is an important detail among many others that can make a company to look attractive or not. Details are what makes a difference between being below average or above average. The presentation should have never been removed but simply replaced overnight with a clear notice on their website stating that a new version is now available. I also believe they should be updating their shareholders in a way or another on where they are at with their phase 1a. Not saying they should be providing prematured result but at least when they believe they could be providing us with some result. They could also inform us that results may or will take longer than expected as long as they keep us inform. This would be an improvment in transparency and also help building momentum and expectation (good or bad). I am also disapointed about PL intervention in the article. What is he trying to do ? Unfortunaly I am losing confidence. My confidence in him was very high. I now feel that he is just taking himself to seriously and giving the impression that he has a very high impression of himself. I dont like that. I now believe he can come to shareholders with no shame and annouce us that a not friendly dilutive financing is required and go on with it. He needs to rebuilt my confidence. Good result or not, he and TH must improve their communication to actual shareholders and to the potentials one.
SPCEO1 wrote: Once the corporate presentation came out with no significant new info, we already could be pretty confident these meetings will not yield anything too important. My best guess is either they were very lazy or very overworked and could not get the presentation replaced in a timely fashion or something TH was hoping would happen didn't actually happen. 

realitycheck4u wrote: As there was no news release thus far, it is very possible that they are going to have discussions about nothing new. Wonder how that goes down.

 




<< Previous
Bullboard Posts
Next >>